Heart Diseases Clinical Trials

62 recruiting

Heart Diseases Trials at a Glance

64 actively recruiting trials for heart diseases are listed on ClinicalTrialsFinder across 6 cities in 45 countries. The largest study group is Not Applicable with 27 trials, with the heaviest enrollment activity in New York, Barcelona, and Boston. Lead sponsors running heart diseases studies include Abbott Medical Devices, Insel Gruppe AG, University Hospital Bern, and Nantes University Hospital.

Browse heart diseases trials by phase

Treatments under study

About Heart Diseases Clinical Trials

Looking for clinical trials for Heart Diseases? There are currently 62 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Heart Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Heart Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 64 trials

Recruiting
Not Applicable

Ablation of Consecutive Atrial Tachycardia

Arrhythmias, CardiacHeart DiseasesAtrial Tachycardia+1 more
Evangelical Hospital Düsseldorf100 enrolled6 locationsNCT05239364
Recruiting
Not Applicable

Sternal Plating High Risk

Heart Diseases
University Hospitals Cleveland Medical Center250 enrolled1 locationNCT06660186
Recruiting

Mayo AVC Registry and Biobank

CardiomyopathiesCardiovascular DiseasesHeart Diseases+5 more
Mayo Clinic1,000 enrolled2 locationsNCT03049254
Recruiting
Not Applicable

To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Puncture for Left Atrial Access.

Atrial FibrillationArrhythmias, CardiacHeart Diseases
Starmed70 enrolled1 locationNCT06358391
Recruiting
Not Applicable

Randomization of Single vs Multiple Arterial Grafts

Heart DiseasesCoronary Artery Disease
Weill Medical College of Cornell University4,300 enrolled59 locationsNCT03217006
Recruiting
Phase 2

Transition to KPL-387 Monotherapy Dosing & Administration Study

PericarditisHeart DiseasesRecurrent Pericarditis
Kiniksa Pharmaceuticals International, plc80 enrolled12 locationsNCT07288216
Recruiting
Not Applicable

Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

Heart FailureCardiovascular DiseasesMyocardial Ischemia+5 more
AliveCor1,000 enrolled4 locationsNCT06271577
Recruiting
Not Applicable

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Heart FailureCardiovascular DiseasesHeart Diseases+3 more
Cardiac Dimensions, Inc.300 enrolled92 locationsNCT03142152
Recruiting

Abbott Structural Heart Device Registry

Heart DiseasesValvular Heart DiseasePFO - Patent Foramen Ovale+3 more
Abbott Medical Devices2,500 enrolled28 locationsNCT06590467
Recruiting

Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry

DeathPostoperative ComplicationsHeart Diseases+1 more
CMC Ambroise Paré8,000 enrolled1 locationNCT03209674
Recruiting
Not Applicable

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Heart DiseasesCoronary Artery DiseaseCoronary Artery Bypass Grafting
Weill Medical College of Cornell University2,300 enrolled146 locationsNCT04124120
Recruiting
Not Applicable

Robotic Transjugular Transcatheter Tricuspid Valve Replacement

Tricuspid Regurgitation (TR)Transcatheter Valve ReplacementValvular Heart Diseases
Prince of Wales Hospital, Shatin, Hong Kong10 enrolled1 locationNCT07516145
Recruiting
Phase 3

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company582 enrolled98 locationsNCT06563895
Recruiting
Not Applicable

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Heart FailureCardiovascular DiseasesHeart Diseases
BrioHealth Solutions, Inc.780 enrolled37 locationsNCT06310031
Recruiting
Phase 4

The Leadless AV Versus DDD Pacing Study

Cardiovascular DiseasesArrhythmias, CardiacHeart Diseases+1 more
Insel Gruppe AG, University Hospital Bern100 enrolled1 locationNCT05498376
Recruiting

Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

Hereditary Heart Diseases
Nantes University Hospital1,000 enrolled15 locationsNCT07257289
Recruiting

Archival of Human Biological Samples in CU-Med Biobank

CancerHealthyDiabetes+4 more
Chinese University of Hong Kong10,000 enrolled1 locationNCT04706481
Recruiting
Phase 3

Lumason® Infusion vs. Bolus Administrations

Heart Diseases
Bracco Diagnostics, Inc106 enrolled6 locationsNCT06400004
Recruiting

Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology

Heart Diseases
Tulane University10,000 enrolled3 locationsNCT06753045
Recruiting

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Inflammatory Bowel DiseasesHeart DiseasesAutoimmune Disease+5 more
University of Chicago1,200 enrolled1 locationNCT01280825